This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Natural Alternatives International, Inc. Announces ISSN Lifetime Achievement Award To Professor Roger Harris For Outstanding Contributions To The Science Of Sports Nutrition

Dr. Harris stated, "Such an award represents the work of many collaborators and research students and, in the case of the beta-alanine project also many years of unbroken research support from Natural Alternatives.  I count myself very fortunate to have participated in two programs that have helped redefine sports nutrition.  I am particularly indebted to the late Professor Eric Hultman of the Karolinska Institute, Stockholm, who died earlier this year, for early mentoring on creatine, and to Dr. John Wise of NAI for 15 years of research partnership."

Mark LeDoux, NAI CEO and Chairman said, "Dr. Harris' extensive study of beta-alanine and his many years of dedication to the field of sports nutrition is the foundation of NAI's comprehensive beta-alanine patent portfolio.  We applaud Dr. Harris and his many academic achievements and look forward to many more years of successful partnership."

NAI's extensive beta-alanine patent portfolio covering various methods and compositions for increasing the anaerobic working capacity in tissues, includes six issued US patents and several pending US patent applications, as well as patents in Canada, Europe, Japan and China.  NAI currently manufactures several nutritional supplements using beta-alanine for existing customers under its patent estate.  NAI also has continued its support of beta-alanine clinical research, collaborating with renowned universities and physicians.

Professor Roger Harris was born in Coventry, Warwickshire, UK, in 1944 and gained a degree in biochemistry from the University of Wales, Aberystwyth, where he also undertook his Masters and PhD.  Following eight years in Sweden in Professor Hultman's laboratory, Professor Harris spent a number of years in the UK pharmaceutical industry before returning to research once again in Sweden, then at the Animal Health Trust in the UK.  From 1997 until his retirement from academic life in 2009, Professor Harris held the chair of Exercise Biochemistry and Sports Science at the University of Chichester, UK.  Although now retired, he continues to collaborate with the Korean National Sport University, the Australian Institute of Sport, the University of Sao Paulo and Nottingham Trent University through his consultancy company, Junipa Ltd.  Professor Harris has authored/co-authored over two hundred research papers as well as numerous book chapters.

NAI, headquartered in San Marcos, California, is a leading formulator, manufacturer and marketer of nutritional supplements and provides strategic partnering services to its customers. Our comprehensive partnership approach offers a wide range of innovative nutritional products and services to our clients including: scientific research, clinical studies, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management and support, packaging and delivery system design, regulatory review and international product registration assistance. For more information about NAI, please see our website at

This press release contains forward-looking statements within the meaning of applicable securities laws that are not historical facts and information. These statements represent our intentions, expectations and beliefs concerning future events, including, among other things, our expectations and beliefs with respect to our beta-alanine patent estate and the use of creatine and beta-alanine dietary supplements, as well as future economic conditions and the impact of such conditions on our business. We wish to caution readers these statements involve risks and uncertainties that could cause actual results and outcomes for future periods to differ materially from any forward-looking statement or views expressed herein. The forward-looking statements contained herein are further qualified by other risks including those set forth from time to time in the documents filed by us with the Securities and Exchange Commission, including our most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q.

2 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,814.59 +2.40 0.01%
S&P 500 2,089.14 +2.55 0.12%
NASDAQ 5,102.8080 +0.33 0.01%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs